Emmanuel Sorbets Selected Research

Emmanuel Sorbets Research Topics

10	Myocardial Infarction 01/2021 - 01/2014
9	Heart Failure 01/2022 - 01/2014
8	Stroke (Strokes) 01/2021 - 01/2014
6	Hemorrhage 01/2021 - 04/2017
6	Thrombosis (Thrombus) 10/2020 - 01/2012
5	ST Elevation Myocardial Infarction 03/2021 - 06/2013
5	Acute Coronary Syndrome 03/2021 - 01/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2012
3	Atrial Fibrillation 01/2021 - 03/2017
3	Hypertension (High Blood Pressure) 01/2020 - 01/2014
2	Peripheral Arterial Disease 01/2021 - 09/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2017
2	Vascular Diseases (Vascular Disease) 01/2019 - 09/2017
2	Ischemic Stroke 01/2018 - 01/2014
2	Atherosclerosis 09/2017 - 01/2012
1	Shock 01/2021
1	Overweight 01/2020
1	Cognitive Dysfunction 09/2019
1	Renal Insufficiency (Renal Failure) 01/2018
1	Pathologic Constriction (Stenosis) 10/2017
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2017
1	Sudden Death 01/2017
1	Non-ST Elevated Myocardial Infarction 10/2016
1	Hypercholesterolemia 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014
1	Type 2 Diabetes Mellitus (MODY) 12/2014
1	Diabetes Mellitus 12/2014
1	Ventricular Remodeling 01/2014
1	Ischemia 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Bundle-Branch Block (Fascicular Block) 09/2012
1	Hypertrophy 09/2012
1	Atherosclerotic Plaque (Atheroma) 01/2012
1	Stable Angina 01/2012

7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2014
3	otamixabanIBA 03/2021 - 10/2020
3	RivaroxabanIBA 01/2021 - 01/2019
2	SaltsIBA 11/2019 - 01/2014
2	AnticoagulantsIBA 09/2019 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 02/2016
1	Eptifibatide (Integrilin)FDA Link 03/2021
1	Heparin (Liquaemin)FDA LinkGeneric 03/2021
1	Troleandomycin (TAO)FDA Link 03/2021
1	Ala(2)- enkephalinamide-Met (DAME)IBA 01/2021
1	edoxabanIBA 02/2020
1	RubidiumIBA 01/2020
1	Estrogens (Estrogen)FDA Link 11/2019
1	Progestins (Progestagens)IBA 11/2019
1	Vitamin K FDA Link 09/2019
1	CalciumIBA 01/2019
1	ProcalcitoninIBA 07/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2017
1	Streptokinase FDA Link 04/2017
1	Atrial Natriuretic Factor (ANF)IBA 03/2017
1	trans-crotonin (CTN)IBA 10/2016
1	TroponinIBA 10/2016
1	Troponin T (Troponin T1)IBA 10/2016
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Clopidogrel (Plavix)FDA Link 12/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2014
1	Angiotensin Receptor AntagonistsIBA 07/2014
1	CreatinineIBA 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Pancreatic Elastase (Elastase)IBA 01/2012
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2012

7	Therapeutics 02/2020 - 06/2013
4	Stents 10/2020 - 01/2018
3	Percutaneous Coronary Intervention 03/2021 - 10/2017
1	Secondary Prevention 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2017
1	Defibrillators (Defibrillator) 01/2017
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2017
1	Drug-Eluting Stents 12/2014
1	Prostheses and Implants (Prosthesis) 09/2012